Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 70901-70950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05940051
Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma
PHASE2Recruiting
35 participants
Started: Jul 20, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05861102
Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)
PHASE3Recruiting
258 participants
Started: Jul 20, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05935605
Pulmonary Hypertension in Left Heart Disease
N/ARecruiting
3,000 participants
Started: Jul 20, 2023 · Completed: May 31, 2028
3 conditions2 sponsors1 location
NCT05942521
Effects of Subconscious Memory Extinction in Patients With Alcohol Dependence and Its Mechanism
NARecruiting
90 participants
Started: Jul 20, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05949775
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
NANot yet recruiting
20 participants
Started: Jul 20, 2023 · Completed: Mar 20, 2026
1 condition2 sponsors0 locations
NCT05850962
Individualised Blood Pressure Targets Versus Standard Care Among Critically Ill Patients With Shock
NARecruiting
1,260 participants
Started: Jul 20, 2023 · Completed: Oct 30, 2028
2 conditions1 sponsor1 location
NCT05669664
Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers
PHASE2Recruiting
21 participants
Started: Jul 20, 2023 · Completed: Apr 11, 2027
4 conditions1 sponsor27 locations
NCT05720468
Exercise for Cognitive Excellence in Parkinson's Disease
NARecruiting
32 participants
Started: Jul 20, 2023 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05895981
Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.
NARecruiting
15 participants
Started: Jul 20, 2023 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT05967741
The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation
NARecruiting
24 participants
Started: Jul 20, 2023 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT05936151
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
PHASE2Active, not recruiting
146 participants
Started: Jul 20, 2023 · Completed: Nov 30, 2025
3 conditions1 sponsor42 locations
NCT05859815
The Role of Mechanical Diagnosis and Therapy in the Management of Concussion
N/ARecruiting
100 participants
Started: Jul 20, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor2 locations
NCT05953012
Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration
PHASE1Recruiting
36 participants
Started: Jul 20, 2023 · Completed: Oct 30, 2025
1 condition2 sponsors4 locations
NCT05954429
A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-isolated Hepatic Metastatic Colorectal Cancer: a Single-center, Phase 2 Study
PHASE2Not yet recruiting
50 participants
Started: Jul 20, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05819619
Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days
EARLY_PHASE1Recruiting
168 participants
Started: Jul 20, 2023 · Completed: Jul 19, 2025
2 conditions1 sponsor1 location
NCT05943548
Omuyambi: Traditional Healer Support to Improve HIV Viral Suppression in Rural Uganda
NARecruiting
650 participants
Started: Jul 20, 2023 · Completed: Jul 31, 2027
1 condition3 sponsors1 location
NCT05940116
A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors
PHASE1Not yet recruiting
322 participants
Started: Jul 20, 2023 · Completed: Jul 30, 2027
2 conditions1 sponsor1 location
NCT06138769
Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma
PHASE2Active, not recruiting
50 participants
Started: Jul 20, 2023 · Completed: Nov 1, 2027
1 condition21 sponsors1 location
NCT06133335
Cystic Fibrosis and Periodontal Diseases
NARecruiting
50 participants
Started: Jul 20, 2023 · Completed: Jan 20, 2025
3 conditions1 sponsor1 location
NCT06172062
Establishment and Application of an Artificial Intelligence Algorithm for Automatic Identification of Intraoperative Bleeding During Laparoscopic Pancreaticoduodenectomy
N/ARecruiting
400 participants
Started: Jul 20, 2023 · Completed: Mar 30, 2024
1 condition1 sponsor1 location
NCT05163275
Dyspnea Facial Recognition During Weaning
N/ARecruiting
100 participants
Started: Jul 20, 2023 · Completed: Aug 3, 2026
1 condition1 sponsor1 location
NCT06031636
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma
N/ARecruiting
15 participants
Started: Jul 20, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05956951
Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation
NARecruiting
200 participants
Started: Jul 20, 2023 · Completed: Jun 30, 2028
1 condition2 sponsors1 location
NCT05803876
Cerebral Perfusion Variation During Blood Pressure Changes Under General Anesthesia
N/ARecruiting
100 participants
Started: Jul 20, 2023 · Completed: Aug 31, 2025
1 condition3 sponsors1 location
NCT05897177
Investigating the Pathophysiological Nature of Homosexuality
N/ANot yet recruiting
500 participants
Started: Jul 20, 2023 · Completed: Apr 20, 2028
1 condition2 sponsors0 locations
NCT05756322
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
PHASE1/PHASE2Recruiting
90 participants
Started: Jul 20, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors14 locations
NCT05678634
Optimizing Feedback-based Learning in Children With Developmental Language Disorder
NARecruiting
100 participants
Started: Jul 20, 2023 · Completed: Oct 1, 2027
1 condition1 sponsor1 location
NCT05804773
Cerebral Perfusion Variation During Blood Pressure Changes in ICU
N/ARecruiting
92 participants
Started: Jul 20, 2023 · Completed: Nov 30, 2025
1 condition3 sponsors1 location
NCT05968001
Obinutuzumab in Chinese Real-world Patients With iNHL
N/ANot yet recruiting
400 participants
Started: Jul 20, 2023 · Completed: Jul 20, 2026
1 condition1 sponsor25 locations
NCT05971719
Validation of a System Using Aerosol Glycerine to Detect and Localize Intraoperatively Pulmonary Air Leaks
NARecruiting
200 participants
Started: Jul 20, 2023 · Completed: Jul 1, 2027
1 condition1 sponsor1 location
NCT05191641
Effect of Individualized Nursing Care for Parents of Pediatric Oncology Patients
NARecruiting
70 participants
Started: Jul 20, 2023 · Completed: Jan 15, 2025
2 conditions1 sponsor2 locations
NCT05939232
Registry of X-linked Adrenoleukodystrophy
N/ARecruiting
200 participants
Started: Jul 20, 2023 · Completed: Dec 1, 2028
1 condition1 sponsor1 location
NCT05800405
Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
EARLY_PHASE1Recruiting
9 participants
Started: Jul 20, 2023 · Completed: Oct 20, 2025
2 conditions2 sponsors1 location
NCT06354231
DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC
PHASE2Recruiting
20 participants
Started: Jul 20, 2023 · Completed: Dec 30, 2026
3 conditions1 sponsor1 location
NCT06016309
The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis
N/ARecruiting
500 participants
Started: Jul 20, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05983107
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
PHASE2Recruiting
102 participants
Started: Jul 20, 2023 · Completed: Jul 15, 2027
2 conditions1 sponsor1 location
NCT06676410
Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants
PHASE2Recruiting
40 participants
Started: Jul 20, 2023 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT06261892
Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine
NARecruiting
300 participants
Started: Jul 20, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05639933
Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
PHASE2Recruiting
152 participants
Started: Jul 19, 2023 · Completed: Dec 30, 2026
3 conditions2 sponsors8 locations
NCT05806801
Metabolic Adaptations to Weight Loss With and Without Exercise
NARecruiting
68 participants
Started: Jul 19, 2023 · Completed: May 31, 2028
6 conditions1 sponsor1 location
NCT05750966
Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis
NARecruiting
440 participants
Started: Jul 19, 2023 · Completed: Sep 1, 2026
1 condition2 sponsors31 locations
NCT07105475
Treatment of ADHD Using High and Low Frequency Paired Associative Deep Transcranial Magnetic Stimulation
NARecruiting
90 participants
Started: Jul 19, 2023 · Completed: Sep 1, 2028
4 conditions2 sponsors1 location
NCT05889052
Perennial Malaria Chemoprevention (PMC) in Cameroon
N/AActive, not recruiting
2,080 participants
Started: Jul 19, 2023 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT06220318
Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
155 participants
Started: Jul 19, 2023 · Completed: Aug 30, 2026
1 condition1 sponsor2 locations
NCT05847348
68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients
PHASE3Recruiting
110 participants
Started: Jul 19, 2023 · Completed: Jul 30, 2026
3 conditions2 sponsors8 locations
NCT07096206
Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study
N/AActive, not recruiting
27 participants
Started: Jul 19, 2023 · Completed: Nov 19, 2026
1 condition1 sponsor2 locations
NCT05880706
A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
PHASE2Active, not recruiting
198 participants
Started: Jul 19, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT04621279
Cool Prime Comparative Effectiveness Study for Mild HIE
N/ARecruiting
460 participants
Started: Jul 19, 2023 · Completed: Jan 1, 2029
1 condition17 sponsors1 location
NCT06167044
Effect of Thoracic Mobilization on Lumbar Radiculopathy
NARecruiting
34 participants
Started: Jul 19, 2023 · Completed: Feb 29, 2024
1 condition1 sponsor1 location
NCT05974150
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
N/ARecruiting
25 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2025
5 conditions1 sponsor7 locations